European Cancer Organisation

European Cancer Organisation
OnlineEditor81 · CC BY-SA 4.0 · source
Name	European Cancer Organisation
Abbreviation	ECO
Formation	1981
Headquarters	Brussels
Region served	Europe
Type	Non-governmental organization
Leader title	Chief Executive
Leader name	(varies)
Website	(not displayed)

European Cancer Organisation is a Brussels-based non-governmental organization focused on reducing the burden of cancer across Europe. It brings together professional societies, patient groups, research institutions and healthcare providers from United Kingdom, France, Germany, Italy and other Council of Europe members to align clinical practice, policy and research. The Organisation convenes stakeholders from World Health Organization, European Commission, European Parliament, European Medicines Agency and national health ministries to promote equitable cancer care.

History

The Organisation was formed in 1981 against a backdrop of growing activity by Union for International Cancer Control, International Agency for Research on Cancer, European Society for Medical Oncology, European Society of Surgical Oncology and national cancer societies such as Cancer Research UK, Ligue contre le Cancer and Deutsche Krebsgesellschaft. Early conferences brought together delegates from World Cancer Congress, European Cancer Congress, American Society of Clinical Oncology and regional bodies including Nordic Cancer Union and Mediterranean Society of Oncology. Over subsequent decades it engaged with landmark events and frameworks like the European Health Forum Gastein, the Lisbon Treaty political context, the Horizon 2020 research programme and the establishment of European Reference Networks. The Organisation’s archives document interactions with figures and institutions such as Dame Cicely Saunders, Sir Richard Doll, Bernard Fisher, European Commissioner for Health holders and national oncology centres including Institut Gustave Roussy, German Cancer Research Center, Istituto Nazionale Tumori and Catalan Institute of Oncology.

Mission and Objectives

The Organisation’s mission aligns with priorities set by World Health Organization Regional Office for Europe, European Commission Directorate-General for Health and Food Safety, OECD Health Division and specialty societies like European Society for Radiotherapy and Oncology. Objectives include improving outcomes championed by European Cancer Patient Coalition, narrowing disparities highlighted by European Observatory on Health Systems and Policies, promoting guidelines developed by National Institute for Health and Care Excellence, NCCN, ESMO Guidelines Committee and fostering multidisciplinary care modeled by European School of Oncology. It emphasizes evidence synthesis from Cochrane Collaboration, translational research supported by European Molecular Biology Laboratory and implementation science resonating with European Implementation Collaborative.

Governance and Structure

Governance mirrors comparable federations such as European Hematology Association and International Psycho-Oncology Society, with a Board composed of representatives from member societies like European Society for Paediatric Oncology, European Society for Medical Oncology, European Society for Radiology and patient organisations including European Cancer Patient Coalition. The Secretariat in Brussels liaises with institutions such as Council of the European Union, European Parliament committees and regulatory bodies like European Medicines Agency. Advisory committees draw experts from Royal Marsden Hospital, Charité – Universitätsmedizin Berlin, Centre Léon Bérard and research funders like European Research Council and Cancer Research UK. Annual General Meetings follow practices of World Health Assembly and elect officers comparable to leadership in Union for International Cancer Control.

Programs and Initiatives

Programs include professional development modelled on European School of Oncology courses, quality assurance initiatives akin to European Society for Quality in Healthcare, multidisciplinary care pathways inspired by European Reference Networks, and awareness campaigns coordinated with European Cancer Patient Coalition and national campaigns such as Pink Ribbon initiatives in Netherlands and Belgium. It hosts congresses similar to European Cancer Congress and workshops reflecting themes from ASCO Annual Meeting and ESC Congress. Initiatives target screening programmes referenced against European Commission Initiative on Breast Cancer, HPV vaccination strategies aligned with European Centre for Disease Prevention and Control, and survivorship projects informed by research from Macmillan Cancer Support and Susan G. Komen.

Partnerships and Collaborations

The Organisation partners with multinational entities such as World Health Organization, European Commission, European Parliament, European Medicines Agency and charitable funders like Wellcome Trust, Bill & Melinda Gates Foundation and Fondation ARC. It collaborates with academic centres including University College London, Karolinska Institutet, University of Oxford, Université Paris-Saclay and networks like European Cancer Research Consortium, BIOBANKING and Biomolecular Resources Research Infrastructure and European Organisation for Research and Treatment of Cancer. Corporate engagement includes dialogue with pharmaceutical consortia represented at EFPIA and diagnostics stakeholders active in European Diagnostic Manufacturers Association. Partnerships extend to patient groups such as Breast Cancer Now, European LeukemiaNet and advocacy groups like Stand Up To Cancer.

Advocacy and Policy Work

Advocacy efforts engage with legislative and policy venues including the European Parliament, European Commission, national health ministries and agencies such as National Institute for Health and Care Excellence and Haute Autorité de Santé. Policy outputs draw on evidence from International Agency for Research on Cancer monographs and analysis by OECD and European Observatory on Health Systems and Policies. Campaign priorities include tobacco control aligned with WHO Framework Convention on Tobacco Control, vaccination policy in step with European Centre for Disease Prevention and Control, equitable access campaigns similar to those by European Patients’ Forum, and research funding agendas reflected in Horizon Europe work programmes. Statements have referenced major public health events including responses to COVID-19 pandemic impacts on cancer services and coordination with emergency policies from European Civil Protection Mechanism.

Funding and Membership

Funding streams resemble those of peer organisations like European Society for Medical Oncology and Union for International Cancer Control, mixing membership dues from professional societies, grants from European Commission, contracts with agencies such as European Centre for Disease Prevention and Control, charitable donations from foundations like Wellcome Trust and industry partnerships regulated under European Transparency Initiative. Membership comprises national cancer societies, clinical specialty organisations (for example European Association of Urology), academic institutions such as KU Leuven, University of Barcelona, patient organisations including European Cancer Patient Coalition and research networks like EORTC. Financial governance follows standards similar to International Financial Reporting Standards applied by nonprofits and reporting expected by funders such as European Research Council.

Category:Cancer organisations in Europe